DK1273293T3 - Suspension af fenofibrat i en oplösning af hydrofil polymer - Google Patents

Suspension af fenofibrat i en oplösning af hydrofil polymer

Info

Publication number: DK1273293T3
Authority: DK; Denmark
Prior art keywords: fenofibrate; suspension; solution; hydrophilic polymer; hydrophilic
Prior art date: 1997-01-17

Application number

DK02018028T

Other languages

English (en)

Inventor

Andre Stamm

Pawan Seth

Original Assignee

Fournier Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-17

Filing date

1998-01-16

Publication date

2005-06-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9502710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1273293(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-01-16 Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa

2005-06-27 Application granted granted Critical

2005-06-27 Publication of DK1273293T3 publication Critical patent/DK1273293T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DK02018028T 1997-01-17 1998-01-16 Suspension af fenofibrat i en oplösning af hydrofil polymer DK1273293T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9700479A FR2758459B1 (fr)	1997-01-17	1997-01-17	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
EP98900125A EP0952829B1 (fr)	1997-01-17	1998-01-16	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation

Publications (1)

Publication Number	Publication Date
DK1273293T3 true DK1273293T3 (da)	2005-06-27

Family

ID=9502710

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
DK98900125T DK0952829T3 (da)	1997-01-17	1998-01-16	Farmaceutisk præparat af fenofibrat med høj biologisk tilgængelighed og fremgangsmåde til dets fremstilling
DK02018028T DK1273293T3 (da)	1997-01-17	1998-01-16	Suspension af fenofibrat i en oplösning af hydrofil polymer
DK02018029T DK1273294T3 (da)	1997-01-17	1998-01-16	Farmaceutisk præparat af fenofibrat med höj biologisk tilgængelighed og fremgangsmåde til dets fremstilling
DK02018031T DK1275387T3 (da)	1997-01-17	1998-01-16	Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK08021428.1T DK2050445T4 (da)	1997-01-17	1998-01-16	Farmaceutisk sammensætning af phenofibrat med forøget biotilgængelighed samt fremgangsmåde til dens fremstilling

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK98900125T DK0952829T3 (da)	1997-01-17	1998-01-16	Farmaceutisk præparat af fenofibrat med høj biologisk tilgængelighed og fremgangsmåde til dets fremstilling

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
DK02018029T DK1273294T3 (da)	1997-01-17	1998-01-16	Farmaceutisk præparat af fenofibrat med höj biologisk tilgængelighed og fremgangsmåde til dets fremstilling
DK02018031T DK1275387T3 (da)	1997-01-17	1998-01-16	Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK08021428.1T DK2050445T4 (da)	1997-01-17	1998-01-16	Farmaceutisk sammensætning af phenofibrat med forøget biotilgængelighed samt fremgangsmåde til dens fremstilling

Country Status (35)

Country	Link
US (18)	US6074670A (da)
EP (6)	EP1275387B1 (da)
JP (6)	JP4219988B2 (da)
KR (2)	KR100391104B1 (da)
CN (2)	CN1278678C (da)
AR (1)	AR011411A1 (da)
AT (4)	ATE291911T1 (da)
BR (1)	BR9806738A (da)
CA (5)	CA2372576C (da)
CY (4)	CY2396B1 (da)
CZ (1)	CZ297251B6 (da)
DE (5)	DE69811855T2 (da)
DK (5)	DK0952829T3 (da)
DZ (1)	DZ2398A1 (da)
EE (1)	EE04042B1 (da)
EG (1)	EG23978A (da)
ES (5)	ES2254569T3 (da)
FR (1)	FR2758459B1 (da)
HU (3)	HU228849B1 (da)
ID (1)	ID22528A (da)
IL (1)	IL130790A0 (da)
IN (1)	IN187906B (da)
IS (1)	IS5097A (da)
MA (1)	MA26466A1 (da)
NO (2)	NO329200B1 (da)
NZ (1)	NZ336462A (da)
PL (1)	PL194802B1 (da)
PT (4)	PT1275387E (da)
RU (3)	RU2238089C2 (da)
SK (1)	SK285847B6 (da)
TN (1)	TNSN98009A1 (da)
TR (1)	TR199901660T2 (da)
UA (1)	UA61096C2 (da)
WO (1)	WO1998031361A1 (da)
ZA (1)	ZA98324B (da)

Families Citing this family (170)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7255877B2 (en) *	1996-08-22	2007-08-14	Jagotec Ag	Fenofibrate microparticles
FR2758459B1 (fr) *	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2783421B1 (fr) *	1998-09-17	2000-11-24	Cll Pharma	Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
SE9803240D0 (sv) *	1998-09-24	1998-09-24	Diabact Ab	A pharmaceutical composition having a rapid action
IL143197A0 (en) *	1998-11-20	2002-04-21	Rtp Pharma Inc	Dispersible phospholipid stabilized microparticles
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EG23951A (en) *	1999-03-25	2008-01-29	Otsuka Pharma Co Ltd	Cilostazol preparation
JP4748839B2 (ja) *	1999-03-25	2011-08-17	大塚製薬株式会社	シロスタゾール製剤
CA2270306C (en) *	1999-04-27	2000-09-26	Bernard Charles Sherman	Pharmaceutical compositions comprising co-micronized fenofibrate
US6465011B2 (en)	1999-05-29	2002-10-15	Abbott Laboratories	Formulations comprising lipid-regulating agents
US6368620B2 (en)	1999-06-11	2002-04-09	Abbott Laboratories	Formulations comprising lipid-regulating agents
US6982281B1 (en)	2000-11-17	2006-01-03	Lipocine Inc	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
FR2803203B1 (fr) *	1999-12-31	2002-05-10	Fournier Ind & Sante	Nouvelles formulations galeniques du fenofibrate
US6531158B1 (en) *	2000-08-09	2003-03-11	Impax Laboratories, Inc.	Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US8586094B2 (en)	2000-09-20	2013-11-19	Jagotec Ag	Coated tablets
US7276249B2 (en) *	2002-05-24	2007-10-02	Elan Pharma International, Ltd.	Nanoparticulate fibrate formulations
US20080241070A1 (en) *	2000-09-21	2008-10-02	Elan Pharma International Ltd.	Fenofibrate dosage forms
US20030224058A1 (en) *	2002-05-24	2003-12-04	Elan Pharma International, Ltd.	Nanoparticulate fibrate formulations
US7125565B2 (en)	2000-12-01	2006-10-24	Kyowa Hakko Kogyo Co., Ltd.	Composition improved in the solubility or oral absorbability
US6982251B2 (en) *	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
FR2819720B1 (fr)	2001-01-22	2004-03-12	Fournier Lab Sa	Nouveaux comprimes de fenofibrate
SI1413331T1 (sl)	2001-01-26	2008-02-29	Schering Corp	Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
JP4711600B2 (ja)	2001-01-26	2011-06-29	シェーリングコーポレイション	シトステロール血症の処置のための置換アゼチジノン化合物の使用
AU2001259099B2 (en) *	2001-02-22	2005-12-22	Skyepharma Canada Inc.	Fibrate-statin combinations with reduced fed-fasted effects
JPWO2002069957A1 (ja) *	2001-03-01	2004-07-02	グレラン製薬株式会社	フェノフィブラート含有組成物
BR0210867A (pt) *	2001-07-06	2004-06-29	Lifecycle Pharma As	Processo para a preparação de um material particulado, métodos para aglomeração controlada de um material sólido finamente disperso, para melhorar a biodisponibilidade de uma substância terapêutica e/ou profilaticamente ativa, e para melhorar a vida em prateleira de uma composição farmacêutica, material articulado, composição farmacêutica, uso de um veìculo, material particulado farmacêutico, e, uso de aluminossilicato de magnésio e/ou de aluminometassilicato de magnésio
GB0119480D0 (en) *	2001-08-09	2001-10-03	Jagotec Ag	Novel compositions
US20030091634A1 (en) *	2001-09-14	2003-05-15	Pawan Seth	Delayed release tablet of venlafaxin
US7132415B2 (en)	2001-09-21	2006-11-07	Schering Corporation	Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030118647A1 (en) *	2001-12-04	2003-06-26	Pawan Seth	Extended release tablet of metformin
FR2834212B1 (fr) *	2001-12-27	2004-07-09	Besins Int Belgique	Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
US20030220374A1 (en) *	2002-01-14	2003-11-27	Pharmacia Corporation	Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
US20030212138A1 (en) *	2002-01-14	2003-11-13	Pharmacia Corporation	Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
JP2005523262A (ja)	2002-02-01	2005-08-04	ファイザー・プロダクツ・インク	薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
IL164152A0 (en) *	2002-03-26	2005-12-18	Teva Pharma	Drug microparticles
WO2003092659A1 (en) *	2002-05-03	2003-11-13	Skyepharma Canada Inc.	Oral dosage forms comprising fenofibrate
US6828334B2 (en) *	2002-05-23	2004-12-07	Usv Limited	Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
US20070264348A1 (en) *	2002-05-24	2007-11-15	Elan Pharma International, Ltd.	Nanoparticulate fibrate formulations
FR2841138B1 (fr) *	2002-06-25	2005-02-25	Cll Pharma	Composition pharmaceutique solide contenant un principe actif lipophile, son procede de preparation
US20040005339A1 (en) *	2002-06-28	2004-01-08	Shojaei Amir H.	Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
EP1539117A4 (en) *	2002-06-28	2005-12-14	Shire Lab Inc	FORMULATIONS BASED ON FENOFIBRATE AND / OR FENOFIBRATE DERIVATIVES HAVING IMPROVED ORAL BIOAVAILABILITY
EP2295529B2 (en)	2002-07-11	2022-05-18	Basf As	Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
SE0202188D0 (sv) *	2002-07-11	2002-07-11	Pronova Biocare As	A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
EP1553928A1 (en) *	2002-09-24	2005-07-20	Ranbaxy Laboratories, Ltd.	Oral pharmaceutical compositions of fenofibrate having high bioavailability
PL376792A1 (pl) *	2002-10-23	2006-01-09	Glaxosmithkline Biologicals S.A.	Sposoby szczepienia przeciwko malarii
US20040086567A1 (en) *	2002-10-30	2004-05-06	Pawan Seth	Bioequivalent composition of itraconazole and a hydrophilic polymer
CA2504878A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorption inhibitors for the treatment of demyelination
CN100367947C (zh) *	2002-12-04	2008-02-13	徐州恩华赛德药业有限责任公司	具有抗高血脂症的含非诺贝特的药物组合物
JP2006511525A (ja)	2002-12-13	2006-04-06	ヤゴテックアーゲー	ナノ粒子状スピロノラクトン局所製剤
US20080051411A1 (en) *	2002-12-17	2008-02-28	Cink Russell D	Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20040115287A1 (en) *	2002-12-17	2004-06-17	Lipocine, Inc.	Hydrophobic active agent compositions and methods
US7259186B2 (en)	2002-12-17	2007-08-21	Abbott Laboratories	Salts of fenofibric acid and pharmaceutical formulations thereof
EP1572190B1 (en) *	2002-12-17	2007-04-18	Abbott GmbH & Co. KG	Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20040142903A1 (en) *	2003-01-16	2004-07-22	Par Pharmaceutical Inc.	Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
US20040162320A1 (en) *	2003-02-14	2004-08-19	Pawan Seth	Solid composition containing nisoldipine a mixture of polyethylene oxides and an antioxidant
FR2851734B1 (fr) *	2003-02-28	2006-06-09	Galenix Innovations	Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN100439361C (zh)	2003-03-07	2008-12-03	先灵公司	取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
JP4589919B2 (ja)	2003-03-07	2010-12-01	シェーリングコーポレイション	高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
CN1756755A (zh) *	2003-03-07	2006-04-05	先灵公司	取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
WO2004108126A1 (en) *	2003-06-06	2004-12-16	Snowden Pharmaceuticals, Llc	Fibric acid derivatives for the treatment of irritable bowel syndrome
DE10325989A1 (de) *	2003-06-07	2005-01-05	Glatt Gmbh	Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
FR2857591B1 (fr) *	2003-07-17	2007-11-02	Ethypharm Sa	Particules comprenant un principe actif sous forme de co-precipite
ATE540671T1 (de)	2003-08-04	2012-01-15	Bend Res Inc	Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
US20050096390A1 (en) *	2003-10-10	2005-05-05	Per Holm	Compositions comprising fenofibrate and pravastatin
US9173847B2 (en) *	2003-10-10	2015-11-03	Veloxis Pharmaceuticals A/S	Tablet comprising a fibrate
WO2005034908A2 (en) *	2003-10-10	2005-04-21	Lifecycle Pharma A/S	A solid dosage form comprising a fibrate and a statin
US20070014846A1 (en) *	2003-10-10	2007-01-18	Lifecycle Pharma A/S	Pharmaceutical compositions comprising fenofibrate and atorvastatin
KR20060085686A (ko) *	2003-10-10	2006-07-27	라이프사이클 파마 에이/에스	피브레이트를 포함하는 고형 제제
US20050096391A1 (en) *	2003-10-10	2005-05-05	Per Holm	Compositions comprising fenofibrate and rosuvastatin
DE10355461A1 (de)	2003-11-27	2005-06-23	Bayer Healthcare Ag	Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US20050142203A1 (en) *	2003-12-30	2005-06-30	Grant Heinicke	Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same
DE102004002761B4 (de) *	2004-01-20	2017-01-05	Daimler Ag	Verfahren zum Betrieb eines Antriebsstrangs eines Kraftfahrzeugs
EP1559419A1 (en) *	2004-01-23	2005-08-03	Fournier Laboratories Ireland Limited	Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
EP1568369A1 (en)	2004-02-23	2005-08-31	Boehringer Ingelheim Vetmedica Gmbh	Use of meloxicam for the treatment of respiratory diseases in pigs
FR2868079B1 (fr) *	2004-03-29	2007-06-08	Seppic Sa	Tensioactifs sous forme de poudre utilisables dans des comprimes ou des gelules procede de preparation et compositions les contenant
US7244765B2 (en)	2004-06-25	2007-07-17	Cytokine Pharmasciences, Inc	Guanylhydrazone salts, compositions, processes of making and methods of using
US20060024362A1 (en)	2004-07-29	2006-02-02	Pawan Seth	Composition comprising a benzimidazole and process for its manufacture
US8026281B2 (en) *	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate
WO2006060817A1 (en) *	2004-12-03	2006-06-08	Abbott Laboratories	Pharmaceutical compositions
MX2007006775A (es) *	2004-12-06	2008-02-25	Reliant Pharmaceuticals Inc	Composiciones estables de fenofibrato con esteres de acido graso.
CN101098690A (zh) *	2004-12-06	2008-01-02	瑞莱恩特医药品有限公司	用于血脂治疗的ω-3脂肪酸和脂血异常剂
KR101356335B1 (ko) *	2004-12-06	2014-02-06	릴라이언트 파마슈티컬스 인코퍼레이티드	지질 치료를 위한 오메가-3 지방산 및 이상지질혈증 제제
DE102004062475A1 (de) *	2004-12-24	2006-07-06	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
CA2593191A1 (en) *	2005-01-14	2006-07-20	Avax Technologies, Inc.	Method for producing a vaccine for the treatment of cancer
CN101128189A (zh) *	2005-02-25	2008-02-20	弗·哈夫曼-拉罗切有限公司	药物物质分散性改善的片剂
JP2006273849A (ja) *	2005-03-02	2006-10-12	Aska Pharmaceutical Co Ltd	フェノフィブラート含有組成物
EA200701913A1 (ru) *	2005-03-08	2008-08-29	Релайэнт Фармасьютикалз, Инк.	Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
EA200701751A1 (ru) *	2005-03-30	2008-04-28	Тева Фармасьютикал Индастриес Лтд.	Улучшенные составы фенофибрата
EA200701750A1 (ru) *	2005-03-30	2008-02-28	Тева Фармасьютикал Индастриес Лтд.	Улучшенные составы фенофибрата, содержащие ментол или пэг/полоксамер
EP1707197A1 (en)	2005-03-30	2006-10-04	Teva Pharmaceutical Industries Ltd.	Formulations containing fenofibrate and a surfactant mixture
US20070148233A1 (en) *	2005-12-28	2007-06-28	Lerner E I	Pharmaceutical formulations of fenofibrate having improved bioavailability
US20070185199A1 (en) *	2005-04-08	2007-08-09	Ju Tzuchi R	Pharmaceutical formulations
US20070148234A1 (en) *	2005-04-08	2007-06-28	Ju Tzuchi R	Pharmaceutical formulations
MX2007012443A (es) *	2005-04-08	2007-12-13	Abbott Lab	Formulaciones farmaceuticas orales que comprenden acido fenofibrico y/o sus sales.
US20080152714A1 (en) *	2005-04-08	2008-06-26	Yi Gao	Pharmaceutical Formulations
EP1793801A1 (en) *	2005-07-15	2007-06-13	Teva Pharmaceutical Industries Ltd.	Novel granulation process and granulate produced therefrom
US20070014854A1 (en) *	2005-07-15	2007-01-18	Ilan Zalit	Novel granulation process
US20070014853A1 (en) *	2005-07-15	2007-01-18	Ilan Zalit	Pharmaceutical dosage form containing novel pharmaceutical granulate
US20070015833A1 (en) *	2005-07-18	2007-01-18	Moshe Flashner-Barak	Formulations of fenofibrate containing menthol
US20070015834A1 (en) *	2005-07-18	2007-01-18	Moshe Flashner-Barak	Formulations of fenofibrate containing PEG/Poloxamer
DE102005047561A1 (de) *	2005-10-04	2007-04-05	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
EP1785133A1 (en)	2005-11-10	2007-05-16	Laboratoires Fournier S.A.	Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
ES2325450T3 (es)	2005-12-28	2009-09-04	Teva Pharmaceutical Industries Ltd	Formulaciones farmaceuticas de fenofibrato con una biodisponibilidad mejorada.
CA2634094A1 (en) *	2005-12-28	2007-07-05	Teva Pharmaceutical Industries Ltd.	Pharmaceutical formulations of fenofibrate having improved bioavailability
EP2026787B1 (en) *	2006-05-13	2013-12-25	Novo Nordisk A/S	Tablet formulation comprising repaglinide and metformin
CA2656277A1 (en) *	2006-06-26	2008-01-03	Mutual Pharmaceutical Company, Inc.	Active agent formulations, methods of making, and methods of use
ES2376396T3 (es)	2006-06-26	2012-03-13	Amgen Inc.	Método para tratar aterosclerosis.
US20090074872A1 (en) *	2006-06-26	2009-03-19	Mutual Pharmaceutical Company, Inc.	Active Agent Formulations, Methods of Making, and Methods of Use
PL2061427T3 (pl) *	2006-09-15	2011-12-30	Echo Pharmaceuticals Bv	Granulat zawierający substancję farmaceutycznie aktywną i emulgator oraz sposób jego wytwarzania
PL2063861T3 (pl)	2006-09-15	2015-07-31	Echo Pharmaceuticals Bv	Jednostka dawkowania do podawania podjęzykowego, podpoliczkowego lub doustnego nierozpuszczalnych w wodzie substancji aktywnych farmaceutycznie
EA200970378A1 (ru) *	2006-10-13	2009-10-30	Янссен Фармацевтика, Н. В.	Композиции фенилалкилкарбамата
US20110097414A1 (en) *	2007-02-26	2011-04-28	Sandal Roshan Lal	Pharmaceutical compositions comprising adsorbate of fenofibrate
MX2009006114A (es) *	2007-03-02	2009-11-10	Meda Pharmaceuticals Inc	Composiciones que comprenden carisoprodol y metodos de uso de las mismas.
US7872560B2 (en) *	2007-03-19	2011-01-18	Abc Taiwan Electronics Corp.	Independent planar transformer
MY159075A (en)	2007-07-26	2016-12-15	Amgen Inc	Modified lecithin-cholesterol acyltransferase enzymes
US20100285126A1 (en) *	2007-08-02	2010-11-11	Rahul Dabre	Pharmaceutical compositions of fenofibrate
HRP20191104T1 (hr) *	2007-09-25	2019-09-20	Solubest Ltd.	Pripravci koji sadrže lipofilne aktivne spojeve i postupak za njihovu pripremu
US20090202649A1 (en) *	2008-02-06	2009-08-13	Subhash Gore	Fenofibrate formulations
CN102083467B (zh)	2008-03-11	2013-12-25	Aska制药株式会社	固体分散体及其药物组合物、以及它们的制备方法
CA2746887C (en) *	2008-12-15	2016-07-05	Banner Pharmacaps, Inc.	Methods for enhancing the release and absorption of water insoluble active agents
FR2940118B1 (fr)	2008-12-24	2013-08-09	Ethypharm Sa	Formulation pharmaceutique de fenofibrate nanonise
US20100159010A1 (en) *	2008-12-24	2010-06-24	Mutual Pharmaceutical Company, Inc.	Active Agent Formulations, Methods of Making, and Methods of Use
BRPI0922520A2 (pt)	2009-01-02	2016-09-27	Fournier Lab Ireland Ltd	"uso de fibratos"
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
WO2010092925A1 (ja) *	2009-02-12	2010-08-19	あすか製薬株式会社	固体分散体とその医薬組成物、並びにそれらの製造方法
US20120076838A1 (en) *	2009-05-27	2012-03-29	Samyang Biopharmaceuticals Corporation	Poorly soluble drug containing microsphere with improved bioavailabilty and method of preparing the same
US20110217369A1 (en) *	2009-09-03	2011-09-08	Ranbaxy Laboratories Limited	Fenofibrate compositions
KR100980752B1 (ko) *	2009-12-17	2010-09-07	삼일제약주식회사	담체 표면 상에 흡착된 페노피브레이트를 포함하는 과립 및 이를 포함하는 약학 조성물
KR101202994B1 (ko)	2010-04-12	2012-11-21	한미사이언스 주식회사	페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US9795568B2 (en)	2010-05-05	2017-10-24	Boehringer Ingelheim Vetmedica Gmbh	Low concentration meloxicam tablets
WO2011143172A1 (en)	2010-05-11	2011-11-17	Thorium Power, Inc.	Fuel assembly with metal fuel alloy kernel and method of manufacturing thereof
US10192644B2 (en)	2010-05-11	2019-01-29	Lightbridge Corporation	Fuel assembly
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
GB201118182D0 (en)	2011-10-21	2011-12-07	Jagotec Ag	Improvements in or relating to organic compounds
WO2013064853A1 (en)	2011-11-05	2013-05-10	Lupin Atlantis Holdings, S.A.	Reduced dose oral pharmaceutical compositions of fenofibrate
CN104220460A (zh)	2011-12-08	2014-12-17	安姆根有限公司	激动人lcat抗原结合蛋白和它们在疗法中的用途
US9452107B2 (en)	2012-04-16	2016-09-27	New Jersey Institute Of Technology	Systems and methods for superdisintegrant-based composite particles for dispersion and dissolution of agents
US9439860B2 (en)	2012-06-25	2016-09-13	Mylan, Inc.	Fenofibrate formulation
US8722083B2 (en)	2012-06-25	2014-05-13	Mylan, Inc.	Fenofibrate formulation
WO2014091318A1 (en)	2012-12-11	2014-06-19	Lupin Atlantis Holdings, S.A.	Reduced dose pharmaceutical compositions of fenofibrate
EP2842547A1 (en)	2013-08-27	2015-03-04	Freund Pharmatec Ltd.	Improved fenofibrate compositions
WO2015042286A1 (en)	2013-09-18	2015-03-26	Georgetown University	Treating neurodegenerative disease with fenofibrate and analogs thereof
KR101576587B1 (ko) *	2014-02-05	2015-12-10	한양대학교 에리카산학협력단	신규한 페노피브레이트 함유 젤라틴 나노입자
WO2015191282A1 (en)	2014-06-11	2015-12-17	Mallinckrodt Llc	Spray dried compositions having different dissolution profiles and processes for their preparation
US20170246187A1 (en)	2014-08-28	2017-08-31	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
CN104352466A (zh) *	2014-11-17	2015-02-18	辰欣药业股份有限公司	一种非诺贝特组合物及其制剂
US20160361322A1 (en)	2015-06-15	2016-12-15	Lipocine Inc.	Composition and method for oral delivery of androgen prodrugs
CN104922078B (zh) *	2015-06-23	2018-10-23	上海市计划生育科学研究所	非诺贝特迟释微丸、制备方法及应用
KR20220110859A (ko)	2016-03-04	2022-08-09	다이호야쿠힌고교 가부시키가이샤	악성 종양 치료용 제제 및 조성물
US11883404B2 (en)	2016-03-04	2024-01-30	Taiho Pharmaceuticals Co., Ltd.	Preparation and composition for treatment of malignant tumors
US11559530B2 (en)	2016-11-28	2023-01-24	Lipocine Inc.	Oral testosterone undecanoate therapy
CN107049981A (zh) *	2017-04-11	2017-08-18	深圳市泛谷药业股份有限公司	一种速释氨磺必利药物组合物及其制备方法
US11534493B2 (en)	2017-09-22	2022-12-27	Arcutis Biotherapeutics, Inc.	Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents
MX2020009762A (es) *	2018-03-19	2021-01-08	Taiho Pharmaceutical Co Ltd	Composicion farmaceutica que incluye alquil sulfato de sodio.
EP3824296A4 (en)	2018-07-20	2022-04-27	Lipocine Inc.	LIVER DISEASE
HRP20251674T1 (hr)	2019-07-31	2026-02-13	Intas Pharmaceuticals Ltd.	Farmaceutski pripravak koji sadrži inhibitore hmg coa reduktaze i fenofibrat
EP3943071B1 (de)	2020-03-31	2025-06-18	Zurab Durmischchanowitch Khinikadze	Zusammensetzung, enthaltend natürliche lipophile verbindungen, verwendung der zusammensetzung und verfahren zur herstellung der zusammensetzung
KR102489384B1 (ko) *	2020-09-29	2023-01-18	애드파마 주식회사	생체이용율이 개선된 페노피브레이트 입자를 포함하는 약제학적 조성물
AU2023342481A1 (en)	2022-09-15	2025-04-10	Arcutis Biotherapeutics, Inc.	Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug
CN119700739B (zh) *	2025-02-26	2025-06-20	中国人民解放军总医院第三医学中心	非诺贝特在治疗Fuchs角膜内皮营养不良中的应用

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US58004A (en) *		1866-09-11		Improved lap-joint for belting
US58005A (en) *		1866-09-11		Improvement in distilling petroleum and other liquids
US92597A (en) *		1869-07-13		Improved counterpoise gun-carriage
US9496A (en) *		1852-12-21		Method of measuring cloth on the cloth-beam
US104060A (en) *		1870-06-07		Improvement in organ-bellows
US168413A (en) *		1875-10-05		Improvement in hydrants
US57999A (en) *		1866-09-11		Improved composition for roofing
US6655A (en) *		1849-08-21		Eirepboof safe
US57998A (en) *		1866-09-11		Improvement in broom-heads
US5783A (en) *		1848-09-19		Spinoabdominal supporter
US104051A (en) *		1870-06-07		Improvement in handles of sheet-metal spoons, forks
US114839A (en) *		1871-05-16		Improvement in apparatus for aerating beer-barrels
US57997A (en) *		1866-09-11		Improvement in malt-ksln floors
US2953497A (en) *	1953-06-03	1960-09-20	Howard A Press	Therapeutic tablets
US2776996A (en) *	1955-12-22	1957-01-08	Du Pont	Manufacture of beta-methylmercaptopropionaldehyde
CH543472A (fr)	1969-01-31	1973-10-31	Orchimed Sa	Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
FR2314917A1 (fr) *	1975-06-20	1977-01-14	Rhone Poulenc Ind	Procede de fabrication de l'aldehyde beta-methylthiopropionique
GB1579818A (en) *	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
US4344934A (en) *	1978-11-20	1982-08-17	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability
EP0012523B2 (en)	1978-11-20	1988-02-03	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability and process for their preparation
FR2494112B1 (da) *	1980-11-19	1986-01-10	Laruelle Claude
DE3107933A1 (de) *	1981-03-02	1982-09-16	Cassella Ag, 6000 Frankfurt	Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
ZA822995B (en) *	1981-05-21	1983-12-28	Wyeth John & Brother Ltd	Slow release pharmaceutical composition
US4463743A (en) *	1981-12-14	1984-08-07	Brunswick Corporation	Capacitor discharge ignition system for internal combustion engines
FR2532706B1 (fr) *	1982-09-07	1987-04-30	Renault	Dispositif d'amortissement et vibrations d'un coupleur elastique en milieu humide, en particulier pour convertisseur de couple
DE3247118A1 (de) *	1982-12-20	1984-06-20	Cassella Ag, 6000 Frankfurt	Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IE55745B1 (en) *	1983-04-06	1991-01-02	Elan Corp Plc	Sustained absorption pharmaceutical composition
US4684516A (en) *	1983-08-01	1987-08-04	Alra Laboratories, Inc.	Sustained release tablets and method of making same
FR2557459B1 (fr) *	1984-01-02	1986-05-30	Lhd Lab Hygiene Dietetique	Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice
GB8414220D0 (en) *	1984-06-04	1984-07-11	Sterwin Ag	Medicaments in unit dose form
GB8414221D0 (en) *	1984-06-04	1984-07-11	Sterwin Ag	Unit dosage form
IT1180507B (it) *	1984-06-29	1987-09-23	Roberto Valducci	Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
US4721709A (en) *	1984-07-26	1988-01-26	Pyare Seth	Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions
EP0179583A1 (en)	1984-10-04	1986-04-30	Merck & Co. Inc.	A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4649082A (en)	1985-03-07	1987-03-10	Ppg Industries, Inc.	Radiation curable compositions based on radiation curable esters of polyfunctional hydroxyl-containing carboxylic acids
US4716033A (en)	1986-03-27	1987-12-29	Warner-Lambert Company	Medicament adsorbates with surfactant and their preparation
FR2602423B1 (fr) *	1986-08-08	1989-05-05	Ethypharm Sa	Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US5385938B1 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Method of using glycolic acid for treating wrinkles
CH668553A5 (de) *	1987-02-02	1989-01-13	Mepha Ag	Arzneimittel mit verzoegerter wirkstofffreisetzung.
US4859703A (en) *	1987-06-15	1989-08-22	Warner-Lambert Company	Lipid regulating compositions
FR2627696B1 (fr) *	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
DE3807895A1 (de) *	1988-03-10	1989-09-21	Knoll Ag	Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
DE3830353A1 (de) *	1988-09-07	1990-03-15	Basf Ag	Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US4961891A (en) *	1988-10-04	1990-10-09	Garlock, Inc.	Method of making high compressibility gasket material
US4927639A (en) *	1989-02-02	1990-05-22	Warner-Lambert Company	Modified release gemfibrozil composition
US4992277A (en) *	1989-08-25	1991-02-12	Schering Corporation	Immediate release diltiazem formulation
GB9015872D0 (en) *	1990-07-19	1990-09-05	Secr Defence	Production of ceramic filaments
US5145684A (en) *	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
ATE156707T1 (de) *	1991-06-21	1997-08-15	Ilsan Ilac Ve Hammaddeleri San	Neues galenisches verfahren für omeprazol enthaltende pellets
FR2692146B1 (fr) *	1992-06-16	1995-06-02	Ethypharm Sa	Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
PH30929A (en) *	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
IT1264020B (it) *	1993-01-28	1996-09-09	Recordati Chem Pharm	Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
US5905171A (en) *	1995-06-22	1999-05-18	Novus International, Inc.	Process for the preparation of 3-(methylthio)propanal
US5549906A (en) *	1993-07-26	1996-08-27	Pharmacia Ab	Nicotine lozenge and therapeutic method for smoking cessation
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
SE9402422D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr) *	1994-07-26	1996-10-18	Effik Lab	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
FR2723586A1 (fr)	1994-08-11	1996-02-16	Seth Pawan	Nouvelles compositions contenant de la cimetidine et associations en derivant
FR2723536A1 (fr) *	1994-08-11	1996-02-16	Seth Pawan	Composition permettant une liberation selective d'un principe actif
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5510118A (en) *	1995-02-14	1996-04-23	Nanosystems Llc	Process for preparing therapeutic compositions containing nanoparticles
US6348469B1 (en) *	1995-04-14	2002-02-19	Pharma Pass Llc	Solid compositions containing glipizide and polyethylene oxide
US6117453A (en) *	1995-04-14	2000-09-12	Pharma Pass	Solid compositions containing polyethylene oxide and an active ingredient
SI9500173B (sl) *	1995-05-19	2002-02-28	Lek,	Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
ES2236628T3 (es) *	1995-09-21	2005-07-16	Pharma Pass Ii Llc	Composicion farmaceutica que contiene un omeprazol labil de acido, y procedimiento para su preparacion.
DE19608750A1 (de) *	1996-03-06	1997-09-11	Durachemie Gmbh & Co Kg	Verfahren zur Herstellung von Fenofibrat-Präparaten
US6048547A (en) *	1996-04-15	2000-04-11	Seth; Pawan	Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
FR2758459B1 (fr) *	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr)	1997-01-17	1998-07-24	Pharma Pass	Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
US5952396A (en) *	1997-06-16	1999-09-14	Raychem Corporation	Low modulus elastomer
CA2214895C (en) *	1997-09-19	1999-04-20	Bernard Charles Sherman	Improved pharmaceutical composition comprising fenofibrate
US6027747A (en) *	1997-11-11	2000-02-22	Terracol; Didier	Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
US6334192B1 (en) *	1998-03-09	2001-12-25	Ronald S. Karpf	Computer system and method for a self administered risk assessment
US6096341A (en) *	1998-10-30	2000-08-01	Pharma Pass Llc	Delayed release tablet of bupropion hydrochloride
US6033686A (en) *	1998-10-30	2000-03-07	Pharma Pass Llc	Controlled release tablet of bupropion hydrochloride
US6375986B1 (en) *	2000-09-21	2002-04-23	Elan Pharma International Ltd.	Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
US6368622B2 (en)	1999-01-29	2002-04-09	Abbott Laboratories	Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6180138B1 (en)	1999-01-29	2001-01-30	Abbott Laboratories	Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
GB2363866B (en) *	2000-05-31	2002-11-06	Intamission Ltd	Data processing apparatus, method and system
US7276249B2 (en) *	2002-05-24	2007-10-02	Elan Pharma International, Ltd.	Nanoparticulate fibrate formulations
ATE310719T1 (de) *	2000-09-29	2005-12-15	Topotarget Uk Ltd	Carbaminsäurederivate enthaltend eine amidgruppe als hdac-inhibitoren
CA2456732C (en) *	2001-08-07	2012-10-30	Galephar M/F	Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor
DE60210626T2 (de)	2001-08-07	2007-03-15	Laboratoires Smb Sa	Verbesserte pharmazeutische zusammensetzung mit einem ppar-alpha-mittel und verfahren zu ihrer herstellung

1997
- 1997-01-17 FR FR9700479A patent/FR2758459B1/fr not_active Expired - Lifetime
- 1997-12-11 CA CA002372576A patent/CA2372576C/fr not_active Expired - Lifetime
- 1997-12-11 CA CA002219475A patent/CA2219475C/fr not_active Expired - Lifetime
- 1997-12-11 CA CA002448630A patent/CA2448630A1/fr not_active Abandoned
- 1997-12-11 CA CA002448623A patent/CA2448623A1/fr not_active Abandoned
- 1997-12-11 CA CA002372561A patent/CA2372561A1/fr not_active Abandoned
1998
- 1998-01-08 IN IN40DE1998 patent/IN187906B/en unknown
- 1998-01-09 US US09/005,128 patent/US6074670A/en not_active Expired - Lifetime
- 1998-01-13 DZ DZ980008A patent/DZ2398A1/xx active
- 1998-01-14 AR ARP980100155A patent/AR011411A1/es not_active Application Discontinuation
- 1998-01-14 MA MA24926A patent/MA26466A1/fr unknown
- 1998-01-15 TN TNTNSN98009A patent/TNSN98009A1/fr unknown
- 1998-01-15 ZA ZA98324A patent/ZA98324B/xx unknown
- 1998-01-16 CN CNB988018845A patent/CN1278678C/zh not_active Expired - Lifetime
- 1998-01-16 JP JP53332498A patent/JP4219988B2/ja not_active Expired - Lifetime
- 1998-01-16 WO PCT/IB1998/000065 patent/WO1998031361A1/fr not_active Ceased
- 1998-01-16 HU HU1100706A patent/HU228849B1/hu not_active IP Right Cessation
- 1998-01-16 EP EP02018031A patent/EP1275387B1/fr not_active Expired - Lifetime
- 1998-01-16 ID IDW990707A patent/ID22528A/id unknown
- 1998-01-16 PT PT02018031T patent/PT1275387E/pt unknown
- 1998-01-16 DK DK98900125T patent/DK0952829T3/da active
- 1998-01-16 EP EP98900125A patent/EP0952829B1/fr not_active Expired - Lifetime
- 1998-01-16 DK DK02018028T patent/DK1273293T3/da active
- 1998-01-16 DE DE69811855T patent/DE69811855T2/de not_active Expired - Lifetime
- 1998-01-16 DE DE69832108T patent/DE69832108T2/de not_active Expired - Lifetime
- 1998-01-16 AT AT02018028T patent/ATE291911T1/de active
- 1998-01-16 DE DE69829591T patent/DE69829591T2/de not_active Expired - Lifetime
- 1998-01-16 EE EEP199900296A patent/EE04042B1/xx unknown
- 1998-01-16 PT PT80214281T patent/PT2050445E/pt unknown
- 1998-01-16 IL IL13079098A patent/IL130790A0/xx not_active IP Right Cessation
- 1998-01-16 CZ CZ0253599A patent/CZ297251B6/cs not_active IP Right Cessation
- 1998-01-16 AT AT98900125T patent/ATE233556T1/de active
- 1998-01-16 EP EP02018028A patent/EP1273293B1/fr not_active Expired - Lifetime
- 1998-01-16 AT AT02018031T patent/ATE324885T1/de active
- 1998-01-16 ES ES02018029T patent/ES2254569T3/es not_active Expired - Lifetime
- 1998-01-16 ES ES08021428T patent/ES2427252T5/es not_active Expired - Lifetime
- 1998-01-16 NZ NZ336462A patent/NZ336462A/xx not_active IP Right Cessation
- 1998-01-16 ES ES02018031T patent/ES2263714T3/es not_active Expired - Lifetime
- 1998-01-16 HU HU0000808A patent/HU227758B1/hu unknown
- 1998-01-16 SK SK962-99A patent/SK285847B6/sk not_active IP Right Cessation
- 1998-01-16 KR KR10-1999-7006240A patent/KR100391104B1/ko not_active Expired - Lifetime
- 1998-01-16 PT PT98900125T patent/PT952829E/pt unknown
- 1998-01-16 AT AT02018029T patent/ATE307576T1/de active
- 1998-01-16 EP EP08021428.1A patent/EP2050445B2/fr not_active Expired - Lifetime
- 1998-01-16 DE DE29825080U patent/DE29825080U1/de not_active Expired - Lifetime
- 1998-01-16 TR TR1999/01660T patent/TR199901660T2/xx unknown
- 1998-01-16 UA UA99084673A patent/UA61096C2/uk unknown
- 1998-01-16 DK DK02018029T patent/DK1273294T3/da active
- 1998-01-16 EP EP02018029A patent/EP1273294B1/fr not_active Revoked
- 1998-01-16 CN CN021513996A patent/CN1496738B/zh not_active Expired - Lifetime
- 1998-01-16 PT PT02018028T patent/PT1273293E/pt unknown
- 1998-01-16 RU RU2002109747A patent/RU2238089C2/ru active
- 1998-01-16 KR KR10-2002-7014558A patent/KR100415897B1/ko not_active Expired - Fee Related
- 1998-01-16 BR BR9806738-9A patent/BR9806738A/pt not_active IP Right Cessation
- 1998-01-16 RU RU2002109746/15A patent/RU2236850C2/ru active
- 1998-01-16 ES ES02018028T patent/ES2241931T3/es not_active Expired - Lifetime
- 1998-01-16 HU HU0400409A patent/HU230685B1/hu unknown
- 1998-01-16 RU RU99118175/14A patent/RU2196580C2/ru active
- 1998-01-16 ES ES98900125T patent/ES2195308T3/es not_active Expired - Lifetime
- 1998-01-16 DK DK02018031T patent/DK1275387T3/da active
- 1998-01-16 EP EP04011004A patent/EP1468681A1/fr not_active Withdrawn
- 1998-01-16 PL PL334748A patent/PL194802B1/pl unknown
- 1998-01-16 DK DK08021428.1T patent/DK2050445T4/da active
- 1998-01-16 DE DE69834437T patent/DE69834437T2/de not_active Expired - Lifetime
- 1998-01-17 EG EG5298A patent/EG23978A/xx active
1999
- 1999-06-29 IS IS5097A patent/IS5097A/is unknown
- 1999-07-16 NO NO993519A patent/NO329200B1/no not_active IP Right Cessation
2000
- 2000-05-18 US US09/572,330 patent/US6277405B1/en not_active Expired - Lifetime
2001
- 2001-07-06 US US09/899,026 patent/US7037529B2/en not_active Expired - Lifetime
2002
- 2002-02-21 US US10/078,500 patent/US6596317B2/en not_active Expired - Lifetime
- 2002-04-22 US US10/126,875 patent/US6589552B2/en not_active Expired - Lifetime
- 2002-11-06 US US10/288,425 patent/US6652881B2/en not_active Expired - Lifetime
- 2002-11-08 US US10/290,333 patent/US7041319B2/en not_active Expired - Lifetime
2003
- 2003-09-22 US US10/665,522 patent/US20040057999A1/en not_active Abandoned
- 2003-09-22 US US10/665,520 patent/US20040058005A1/en not_active Abandoned
- 2003-09-22 US US10/665,519 patent/US20040057998A1/en not_active Abandoned
- 2003-09-22 US US10/665,517 patent/US20040092597A1/en not_active Abandoned
- 2003-09-22 US US10/665,516 patent/US20040058004A1/en not_active Abandoned
- 2003-09-22 US US10/665,518 patent/US20040057997A1/en not_active Abandoned
- 2003-12-05 CY CY0300091A patent/CY2396B1/xx unknown
2005
- 2005-04-12 JP JP2005115032A patent/JP4365343B2/ja not_active Expired - Lifetime
- 2005-05-06 CY CY0500028A patent/CY2513B1/xx unknown
2006
- 2006-01-26 CY CY0600001A patent/CY2547B1/xx unknown
- 2006-07-11 CY CY0600016A patent/CY2560B1/xx unknown
2007
- 2007-03-21 US US11/723,645 patent/US8343540B2/en not_active Expired - Fee Related
- 2007-03-21 US US11/723,646 patent/US8329214B2/en not_active Expired - Fee Related
- 2007-09-05 JP JP2007230506A patent/JP4943975B2/ja not_active Expired - Lifetime
- 2007-10-30 US US11/979,065 patent/US20080063726A1/en not_active Abandoned
- 2007-10-31 US US11/980,593 patent/US20080064759A1/en not_active Abandoned
2008
- 2008-06-23 US US12/213,671 patent/US20090035379A1/en not_active Abandoned
2009
- 2009-03-11 JP JP2009058055A patent/JP2009120623A/ja not_active Withdrawn
- 2009-03-30 JP JP2009083138A patent/JP2009143967A/ja active Pending
2010
- 2010-01-11 NO NO20100034A patent/NO20100034L/no not_active Application Discontinuation
2011
- 2011-06-07 JP JP2011127648A patent/JP2011173927A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
SK96299A3 (en)	2000-08-14
CA2372561A1 (fr)	1998-07-17
US20040058004A1 (en)	2004-03-25
JP4943975B2 (ja)	2012-05-30
HU228849B1 (hu)	2013-06-28
US20070190136A1 (en)	2007-08-16
FR2758459B1 (fr)	1999-05-07
KR100391104B1 (ko)	2003-07-12
JP2001511156A (ja)	2001-08-07
EP1275387A1 (fr)	2003-01-15
EP1275387B1 (fr)	2006-05-03
HU0400409D0 (hu)	2004-04-28
EG23978A (fr)	2008-02-26
JP4365343B2 (ja)	2009-11-18
PT1275387E (pt)	2006-08-31
HUP0000808A2 (hu)	2000-12-28
US20040057999A1 (en)	2004-03-25
HU230685B1 (en)	2017-08-28
DE69832108T2 (de)	2006-09-21
CY2547B1 (fr)	2008-07-02
US6652881B2 (en)	2003-11-25
UA61096C2 (uk)	2003-11-17
NO20100034L (no)	1999-09-16
US6074670A (en)	2000-06-13
ES2195308T3 (es)	2003-12-01
US20020009496A1 (en)	2002-01-24
EE9900296A (et)	2000-02-15
US20090035379A1 (en)	2009-02-05
US20030104051A1 (en)	2003-06-05
PT2050445E (pt)	2013-08-23
HK1023071A1 (en)	2000-09-01
EP1468681A1 (fr)	2004-10-20
EP2050445B2 (fr)	2021-07-21
US20040092597A1 (en)	2004-05-13
CA2372576C (fr)	2004-02-10
HK1131051A1 (en)	2010-01-15
US20040058005A1 (en)	2004-03-25
NO993519D0 (no)	1999-07-16
US7041319B2 (en)	2006-05-09
WO1998031361A1 (fr)	1998-07-23
CA2219475A1 (fr)	1998-07-17
RU2238089C2 (ru)	2004-10-20
CY2396B1 (en)	2004-09-10
CN1278678C (zh)	2006-10-11
BR9806738A (pt)	2000-02-29
TR199901660T2 (xx)	1999-09-21
AU731964B2 (en)	2001-04-05
EP0952829B1 (fr)	2003-03-05
KR20000070021A (ko)	2000-11-25
ES2254569T3 (es)	2006-06-16
ES2427252T5 (es)	2022-02-14
HU227758B1 (hu)	2012-02-28
HK1065952A1 (en)	2005-03-11
CZ253599A3 (cs)	1999-11-17
ES2241931T3 (es)	2005-11-01
CA2372576A1 (fr)	1998-07-17
RU2196580C2 (ru)	2003-01-20
DK1273294T3 (da)	2006-03-13
EE04042B1 (et)	2003-06-16
EP1273294B1 (fr)	2005-10-26
US7037529B2 (en)	2006-05-02
US20040057997A1 (en)	2004-03-25
MA26466A1 (fr)	2004-12-20
IN187906B (da)	2002-07-20
AU5336798A (en)	1998-08-07
JP2005206614A (ja)	2005-08-04
DE69832108D1 (de)	2005-12-01
EP1273294A1 (fr)	2003-01-08
US20080063726A1 (en)	2008-03-13
CA2448623A1 (fr)	1998-07-17
CN1496738B (zh)	2011-03-30
US20080064759A1 (en)	2008-03-13
US20040057998A1 (en)	2004-03-25
NO993519L (no)	1999-09-16
JP2009143967A (ja)	2009-07-02
ATE291911T1 (de)	2005-04-15
ATE307576T1 (de)	2005-11-15
EP2050445B1 (fr)	2013-06-26
CZ297251B6 (cs)	2006-10-11
DE69811855T2 (de)	2003-12-18
RU2236850C2 (ru)	2004-09-27
DE69811855D1 (de)	2003-04-10
DE29825080U1 (de)	2004-11-04
US6596317B2 (en)	2003-07-22
SK285847B6 (sk)	2007-09-06
DE69834437T2 (de)	2006-11-16
ES2427252T3 (es)	2013-10-30
ATE233556T1 (de)	2003-03-15
ATE324885T1 (de)	2006-06-15
NO329200B1 (no)	2010-09-13
DK2050445T4 (da)	2021-10-18
EP1273293A1 (fr)	2003-01-08
JP2007326878A (ja)	2007-12-20
ZA98324B (en)	1998-08-12
PT1273293E (pt)	2005-06-30
IS5097A (is)	1999-06-29
US20020114839A1 (en)	2002-08-22
PT952829E (pt)	2003-07-31
US20020168413A1 (en)	2002-11-14
IL130790A0 (en)	2001-01-28
KR100415897B1 (ko)	2004-01-24
DK2050445T3 (da)	2013-09-08
CY2560B1 (fr)	2008-07-02
JP4219988B2 (ja)	2009-02-04
DK0952829T3 (da)	2003-06-23
AR011411A1 (es)	2000-08-16
ID22528A (id)	1999-10-28
EP1273293B1 (fr)	2005-03-30
US6589552B2 (en)	2003-07-08
ES2263714T3 (es)	2006-12-16
US8329214B2 (en)	2012-12-11
EP0952829A1 (fr)	1999-11-03
CA2448630A1 (fr)	1998-07-17
US20070184103A1 (en)	2007-08-09
DK1275387T3 (da)	2006-08-28
PL194802B1 (pl)	2007-07-31
FR2758459A1 (fr)	1998-07-24
DE69834437D1 (de)	2006-06-08
JP2011173927A (ja)	2011-09-08
NZ336462A (en)	2000-09-29
EP2050445A2 (fr)	2009-04-22
JP2009120623A (ja)	2009-06-04
US8343540B2 (en)	2013-01-01
HUP0000808A3 (en)	2001-02-28
PL334748A1 (en)	2000-03-13
TNSN98009A1 (fr)	2005-03-15
CA2219475C (fr)	2002-07-09
DZ2398A1 (fr)	2003-06-04
CN1496738A (zh)	2004-05-19
CY2513B1 (en)	2005-12-23
EP2050445A3 (fr)	2009-09-09
CN1243438A (zh)	2000-02-02
DE69829591D1 (de)	2005-05-04
US20030104060A1 (en)	2003-06-05
RU2002109746A (ru)	2004-03-20
DE69829591T2 (de)	2006-02-09
US6277405B1 (en)	2001-08-21

Publication	Publication Date	Title
DK1273293T3 (da)	2005-06-27	Suspension af fenofibrat i en oplösning af hydrofil polymer
DK1019102T3 (da)	2002-05-27	32p-polyphosphazen - radioaktivt mærket antithrombogen polymer
IS4796A (is)	1998-07-13	Vatnssækinn þvagleggur með smápoka er inniheldur vatn
DE69619818D1 (de)	2002-04-18	Mit mikrofasern verstärkte poröse polymerfolie
FI954535A7 (fi)	1995-11-15	Superabsorboiva polymeerivaahto
FI960546L (fi)	1996-08-08	Polymeerin stabilointi stabiililla vapaalla radikaalilla
DE68926846D1 (de)	1996-08-22	Hohle Acrylat-Polymer-Mikrokugeln
DK0918812T3 (da)	2005-04-11	Befugtelige polymerfibre
DE69304961D1 (de)	1996-10-31	Hydrophobe Polymerverbundmembranen
EP0943978A4 (en)	2006-08-23	PROCESSOR WITH LOW POWER CONSUMPTION
DE69419947D1 (de)	1999-09-16	Pfropfpolymerisation
DE69811819D1 (de)	2003-04-10	Polymerbatterie
DE69712709D1 (de)	2002-06-27	Propylen-1-Buten-Copolymer
NO931704L (no)	1993-12-27	Klebende polymer
DE69828130D1 (de)	2005-01-20	Hohlfasermembran-Oxygenator
FR2726280B1 (fr)	1997-10-10	Polymere de methacrylate de methyle a structure ramifiee
DE69607676D1 (de)	2000-05-18	Fester Polymerelektrolyt
DE19782098T1 (de)	1999-11-18	Dialysierapparat vom Hohlfasertyp
DE69517549D1 (de)	2000-07-27	Polymerfilm
DE69227633D1 (de)	1998-12-24	Festpolymerelektrolyte
DE59206145D1 (de)	1996-06-05	Polymerer Festelektrolyt
ITMI921008A0 (it)	1992-04-28	Elettrolita polimerico solido a base polietera
DE69318580D1 (de)	1998-06-18	Photo-und biologisch-abbaubare polymermischungen
GB2285009B (en)	1998-04-08	Porous acrylonitrile polymer fiber
DE69532478D1 (de)	2004-02-26	Polymerfilm